Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Yeo, H. Chan (2013)Hepatitis B virus reactivation associated with anti‐neoplastic therapy
Journal of Gastroenterology and Hepatology, 28
Y. Liaw, J. Kao, T. Piratvisuth, H. Chan, R. Chien, Chun-Jen Liu, E. Gane, S. Locarnini, S. Lim, K. Han, D. Amarapurkar, G. Cooksley, W. Jafri, R. Mohamed, J. Hou, W. Chuang, L. Lesmana, J. Sollano, D. Suh, M. Omata (2012)Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Hepatology International, 6
R. Loomba, Ayana Rowley, R. Wesley, T. Liang, J. Hoofnagle, F. Pucino, G. Csako (2008)Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy
Annals of Internal Medicine, 148
M. Buti, M. Manzano, R. Morillas, M. García-Retortillo, L. Martín, M. Prieto, María Gutiérrez, E. Suárez, M. Rubio, Javier López, P. Castillo, Manuel Rodríguez, J. Zozaya, M. Simón, L. Morano, J. Calleja, M. Yébenes, R. Esteban (2017)Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
PLoS ONE, 12
María Morales, Carmen Sendra, M. Romero-Gómez (2017)Hepatitis B and NAFLD: Lives Crossed.
Annals of hepatology, 16 2
A Liberati (2009)10.1136/bmj.b2700
S. Moses, Z. Lim, M. Sudhanva, S. Devereux, A. Ho, A. Pagliuca, M. Zuckerman, G. Mufti (2006)Lamivudine prophylaxis and treatment of hepatitis B Virus‐exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab
Journal of Medical Virology, 78
W. Seto (2015)Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification.
World journal of hepatology, 7 6
A. Bisceglie, A. Lok, Paul Martin, N. Terrault, R. Perrillo, J. Hoofnagle (2015)Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?
M. Padovan, M. Filippini, A. Tincani, E. Lanciano, E. Bruschi, O. Epis, P. Garau, A. Mathieu, E. Celletti, L. Giani, P. Tomietto, F. Atzeni, P. puttini, F. Zuliani, S. Vita, F. Trotta, A. Grilli, M. Puoti, M. Govoni (2016)Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection
Arthritis Care & Research, 68
S Paul, A Saxena, N Terrin (2016)Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis
Ann Intern Med, 164
Chiun Hsu, Hsiao-Hui Tsou, Shyh‐Jer Lin, Ming-Chung Wang, M. Yao, W. Hwang, W. Kao, C. Chiu, Sheng‐Fung Lin, Johnson Lin, Cheng-Shyong Chang, H. Tien, T. Liu, Pei‐Jer Chen, A. Cheng (2014)Chemotherapy‐induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
Minyue Zhang, Gui-Qi Zhu, Ji-Na Zheng, Z. Cheng, S. Poucke, Ke-Qing Shi, Honghui Huang, Fang-Yuan Chen, M. Zheng (2017)Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis
Expert Review of Anti-infective Therapy, 15
H. Kohrt, Daniel Ouyang, E. Keeffe (2006)Systematic review: lamivudine prophylaxis for chemotherapy‐induced reactivation of chronic hepatitis B virus infection
Alimentary Pharmacology & Therapeutics, 24
R. Perrillo, Paul Martin, A. Lok (2015)Preventing hepatitis B reactivation due to immunosuppressive drug treatments.
JAMA, 313 16
M. Buti, R. Morillas, M. Manzano, M. García-Retortillo, M. Gutierrez, L. Martín, M. Prieto, E. Suárez, F. Gea, Manuel Rodríguez, J. Zozaya, J. López, M. Gomez, M. Simón, L. Morano, A. Pardo, R. Esteban (2014)P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
Journal of Hepatology, 60
Hlebova LIu, Z. Zhao, Hui Yang, F. Liu, Q. Liu, Q. Luo, Q. Yuan, Li-Min Chen, Li-Min Chen, Aizhong Zeng (2013)The effects of nucleoside analogue prophylactic treatment on HBV activation in HBcAb+ patients undergoing immunosuppressive therapy
Journal of Viral Hepatitis, 20
M. Egger, G. Smith, Martin Schneider, C. Minder (1997)Bias in meta-analysis detected by a simple, graphical test
W. Yeo, T. Chan, N. Leung, W. Lam, F. Mo, M. Chu, H. Chan, E. Hui, K. Lei, T. Mok, P. Chan (2009)Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 4
N. Papadopoulos, M. Deutsch, S. Manolakopoulos, Chrysoula Bitsi, Helias Michalakeas, H. Poulakidas, E. Tsironi, S. Giannouli, G. Papatheodoridis, J. Koskinas, D. Pectasides (2017)Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience
European Journal of Gastroenterology & Hepatology, 29
W. Seto, T. Chan, Y. Hwang, D. Wong, J. Fung, K. Liu, H. Gill, Yuk‐Fai Lam, E. Lau, K. Cheung, A. Lie, Ching‐lung Lai, Y. Kwong, M. Yuen (2017)Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study
Y. Braun-Moscovici, M. Braun, T. Saadi, D. Markovits, M. Nahir, A. Balbir-Gurman (2016)Safety of Corticosteroid Treatment in Rheumatologic Patients With Markers of Hepatitis B Viral Infection: Pilot Evaluation Study
JCR: Journal of Clinical Rheumatology, 22
He Huang, Xueying Li, Jun Zhu, S. Ye, Hongyu Zhang, Wei Wang, Xiang-yuan Wu, Jiewen Peng, Bing Xu, Yingcheng Lin, Yabing Cao, Haoran Li, Su-xia Lin, Qing Liu, T. Lin (2014)Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
JAMA, 312 23
A. Liberati, D. Altman, J. Tetzlaff, C. Mulrow, P. Gøtzsche, J. Ioannidis, M. Clarke, P. Devereaux, J. Kleijnen, D. Moher (2009)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
PLoS Medicine, 6
Yi‐Hsiang Huang, L. Hsiao, Ying‐Chung Hong, T. Chiou, Yuan‐Bin Yu, J. Gau, Chun-Yu Liu, Muh-Hwa Yang, C. Tzeng, Pui‐ching Lee, Han‐Chieh Lin, Shou-Dong Lee (2013)Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 22
Sonali Paul, A. Saxena, N. Terrin, K. Viveiros, E. Balk, J. Wong (2016)Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy
Annals of Internal Medicine, 164
H. Maekawa, M. Yazawa, K. Koitabashi, N. Imai, H. Kawarazaki, R. Nakazawa, H. Sasaki, T. Chikaraishi, Y. Shibagaki (2016)Safety of Monitoring Viral and Liver Function Markers in Patients With Prior Resolved Hepatitis B Infection After Kidney Transplantation.
Transplantation proceedings, 48 6
W. Seto, ThomasSau-Yan Chan, Y. Hwang, D. Wong, J. Fung, K. Liu, H. Gill, Yuk‐Fai Lam, A. Lie, Ching‐lung Lai, Y. Kwong, M. Yuen (2014)Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 33
M. Law, Rita Ho, C. Cheung, L. Tam, K. Ma, K. So, B. Ip, J. So, J. Lai, J. Ng, T. Tam (2016)Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
World journal of gastroenterology, 22 28
A. Lok, B. McMahon, Robert Brown, J. Wong, A. Ahmed, W. Farah, J. Almasri, Fares Alahdab, Khalid Benkhadra, Mohamed Mouchli, Siddharth Singh, Essa Mohamed, A. Dabrh, L. Prokop, Zhen Wang, M. Murad, K. Mohammed (2016)Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
M. Barone, A. Notarnicola, G. Lopalco, M. Viggiani, F. Sebastiani, M. Covelli, F. Iannone, A. Avolio, A. Leo, L. Cantarini, G. Lapadula (2015)Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
Jeong-Ju Yoo, E. Cho, Y. Cho, Minjong Lee, Dong Lee, Yuri Cho, Jeong‐Hoon Lee, S. Yu, Sung-Soo Yoon, Jung‐Hwan Yoon, Y. Kim (2015)Efficacy of antiviral prophylaxis in HBsAg‐negative, anti‐HBc positive patients undergoing hematopoietic stem cell transplantation
Liver International, 35
Yi‐Hsiang Huang, Y.-C. Hong, L. Hsiao, T. Chiou, C. Tzeng, Han‐Chieh Lin, Shou-Dong Lee (2012)516 RANDOMIZED CONTROLLED TRIAL OF PROPHYLACTIC ENTECAVIR IN HBSAG-NEGATIVE/ANTI-HBC-POSITIVE LYMPHOMA PATIENTS UNDERGOING RITUXIMAB-BASED CHEMOTHERAPY: PRELIMINARY REPORT
Journal of Hepatology, 56
S. Kim, Chiun Hsu, Yu-Qin Song, K. Tay, X. Hong, Junning Cao, Jin Kim, H. Eom, J. Lee, Jun Zhu, K. Chang, A. Reksodiputro, D. Tan, Y. Goh, Je-Joong Lee, T. Intragumtornchai, W. Chng, A. Cheng, S. Lim, C. Suh, Y. Kwong, W. Kim (2013)Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
European journal of cancer, 49 16
S. Sarin, M. Kumar, G. Lau, Z. Abbas, H. Chan, Chien-Jen Chen, Ding‐Shinn Chen, Huey‐Ling Chen, Pei‐Jer Chen, R. Chien, A. Dokmeci, E. Gane, J. Hou, W. Jafri, J. Jia, Ju Kim, Ching. Lai, Hon-Cheung Lee, S. Lim, Chun-Jen Liu, S. Locarnini, M. Mahtab, R. Mohamed, Masao Omata, J. Park, T. Piratvisuth, B. Sharma, J. Sollano, F. Wang, Lai Wei, Man-Fung Yuen, Shusen Zheng, J. Kao (2015)Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Hepatology International, 10
Yuri Cho, S. Yu, E. Cho, Jeong‐Hoon Lee, Tae Kim, D. Heo, Y. Kim, Jung‐Hwan Yoon (2016)High titers of anti‐HBs prevent rituximab‐related viral reactivation in resolved hepatitis B patient with non‐Hodgkin's lymphoma
Journal of Medical Virology, 88
M. Buti, M. Manzano, R. Morillas, M. García-Retortillo, L. Martín, M. Prieto, M. Gutierrez, E. Suárez, F. Gil-Ares, J. López, P. Castillo, Mayda Rodríguez, J. Zozaya, M. Simón, L. Morano, J. Calleja, R. Esteban (2016)Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)
Journal of Hepatology, 64
G. Wells, G. Wells, B. Shea, B. Shea, Dianne O'Connell, J. Peterson, Welch, M. Losos, P. Tugwell, Sb Ga, G. Zello, J. Petersen (2014)The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
K. Reddy, K. Beavers, S. Hammond, Joseph Lim, Y. Falck-Ytter (2015)American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
Gastroenterology, 148 1
Shasha Lu, Yu Xu, Qi-tian Mu, Lihong Cao, Jian Chen, Zhijuan Zhu, Yinjun Lou, H. Meng, W. Qian, H. Tong, W. Mai, Jian Huang, Wenjuan Yu, Xiaoying Zhao, Jie Jin (2015)The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy
Leukemia & Lymphoma, 56
R. Perrillo, R. Gish, Y. Falck-Ytter (2015)American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
Gastroenterology, 148 1
R. Suurmond, Henk Rhee, T. Hak (2017)Introduction, comparison, and validation of Meta‐Essentials: A free and simple tool for meta‐analysis
Research Synthesis Methods, 8
Maria Guarino, M. Picardi, Anna Vitello, N. Pugliese, Matilde Rea, V. Cossiga, Fabrizio Pane, N. Caporaso, F. Morisco (2017)Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma.
Annals of hepatology, 16 2
J. Higgins, S. Thompson, J. Deeks, D. Altman (2003)Measuring inconsistency in meta-analyses
BMJ : British Medical Journal, 327
G. Germanidis, P. Hytiroglou, M. Zakalka, L. Settas (2012)Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept.
Journal of hepatology, 56 6
Y. Koo, Daniel Tan, I. Tan, M. Tao, W. Chow, S. Lim (2009)Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy
C. Hui, W. Cheung, Hai‐ying Zhang, W. Au, Yui-hung Yueng, A. Leung, N. Leung, J. Luk, A. Lie, Y. Kwong, R. Liang, G. Lau (2006)Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
Gastroenterology, 131 1
Background Until recently, the role of antiviral prophylaxis in preventing hepatitis B virus (HBV) reactivation during immunosuppressive therapy or chemotherapy in patients with resolved HBV infection was unclear. The aim of the study reported here was to compare the efficacy of antiviral prophylaxis versus that of non-prophylaxis in resolved HBV-infected patients undergoing chemotherapy or immunosuppressive therapy. Methods PubMed, the Cochrane library, and the ClinicalTrials.gov website were searched from inception until December 2017. Studies comparing reactivation in prophylaxis versus non-prophylaxis in patients undergoing immu- nosuppressive therapy or chemotherapy were included. The meta-analysis was performed to calculate the relative risk (RR) and the pooled estimates. Results A meta-analysis was conducted of 13 studies (2 randomized controlled trials [RCTs] and 11 cohort studies). The summary RR for HBV reactivation was 0.47 (95% confidence interval [CI] 0.13–1.69) for antiviral prophylaxis versus non-prophylaxis. Both of the RCTs included in the meta-analysis enrolled patients treated with rituximab. Subgroup analyses showed that the two RCTs ± high-quality cohort studies showed a decreased risk of HBV reacti- vation among the antiviral prophylaxis groups (RCT 1: RR 0.13, 95% CI 0.02–0.70; P = 0.02; RCT 2: 0.28, 95% CI 0.08–0.98; P = 0.05). Subgroup analyses further showed that
European Journal of Clinical Pharmacology – Springer Journals
Published: May 29, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.